GlassScriptPhysician profile
Sara Hashemian
NPI 1427054006
$1,290.04
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,047 · 2020: $243.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $311.03 | 2019 | |
| Novo Nordisk INC | $192.83 | 2019-2020 | |
| Pfizer INC. | $141.95 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $116.84 | 2019-2020 | |
| Amgen INC. | $103.09 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $62.76 | 2019 | |
| Sanofi-Aventis U.S. LLC | $52.75 | 2019-2020 | |
| Lilly USA, LLC | $49.97 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.89 | 2019 | |
| Sanofi Pasteur INC. | $41.23 | 2019 | |
| Glaxosmithkline, LLC. | $29.95 | 2020 | |
| Circassia INC. | $26.69 | 2019 | |
| Amarin Pharma, INC. | $25.74 | 2019 | |
| Astellas Pharma US INC | $22.95 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.95 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $16.66 | 2019 | |
| Eisai INC. | $14.13 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.63 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Hashemian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.